SOX2 and glioblastoma: K-Msurvival analysis of 40 clinical GBM patients revealed that abnormal expression of SOX2 isassociated with a poorer prognosis in GBM patients [72].The poor prognosis of GBM patients is likely related to the drug resistance caused bySOX2.